Unknown

Dataset Information

0

Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients.

ABSTRACT:

SUBMITTER: Yanay NB 

PROVIDER: S-EPMC8055922 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Comparison of BNT162b2 (Pfizer-BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients.
| S-EPMC8276570 | biostudies-literature
Unknown Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis.
| S-EPMC9053976 | biostudies-literature
Unknown Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2.
| S-EPMC8415834 | biostudies-literature
Unknown Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.
| S-EPMC8299287 | biostudies-literature
Unknown Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection.
| S-EPMC8471735 | biostudies-literature
Unknown SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
| S-EPMC8425695 | biostudies-literature
Unknown Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.
| S-EPMC8205849 | biostudies-literature
Unknown SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.
| S-EPMC8648019 | biostudies-literature
Unknown BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers.
| S-EPMC8234791 | biostudies-literature
Unknown Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.
| S-EPMC8767896 | biostudies-literature